Daily Market Download

Eli Lilly reported robust 2025 growth , with revenue hitting $65.2 billion. Success was driven by Mounjaro and Zepbound . Future outlook remains bullish, with 2026 revenue projected at $80–83 billion. Key focus areas include orforglipron and retatrutide for obesity and comorbidities.

Brookfield Asset Management reported record 2025 results with $112B raised and $3B in fee-related earnings. Conor Teskey is the new CEO. Strategy focuses on AI infrastructure , credit expansion , and renewable power . A 15% dividend increase reflects strong liquidity.

Old Dominion Freight Line beat Q4 2025 expectations with $1.09 EPS and $1.31 billion in revenue despite a 5.7% YoY decline. High service quality and yield discipline offset lower volumes. Management is cautiously optimistic for 2026, leveraging excess capacity for growth.

Market volatility remains high as tech stocks sell off while Eli Lilly and Alphabet beat earnings. Geopolitical tensions rise as Trump threatens Iran and challenges China over the Panama Canal . Bitcoin fell, and Washington Post began significant layoffs .

AbbVie reported record 2025 revenue of $61.2B, led by the surging immunology drugs Skyrizi and Rinvoq . Despite Humira erosion , management issued strong 2026 guidance . The firm also signed a U.S. government agreement to invest $100B in R&D while ensuring drug affordability.

FOX Q2 2026 reports $5.18B revenue, led by advertising momentum in sports and news. Tubi and FOX One drove digital growth, though EBITDA fell to $692M due to higher programming costs. FOX returned $1.8B via share buybacks and maintained a strong balance sheet .

GE HealthCare reported strong 2025 results with $20.6B in revenue, driven by innovation and robust demand in the US and EMEA. Despite tariff pressures, a record $21.8B backlog and strategic acquisitions like Intelerad position the firm for growth and margin expansion in 2026.

Equifax beat Q4 2025 expectations with $1.55B revenue , fueled by cloud and AI monetization. Despite a weak mortgage market, EFX.AI and proprietary data drove record product vitality. 2026 guidance targets $8.50 EPS and over $1B free cash flow , prioritizing government sector growth.

Stanley Black & Decker reported 2025 results with an adjusted EPS of $4.67 and $15.1B in revenue. Despite volume declines, gross margins expanded to 30.7% due to cost reductions. The company plans to divest its CAM business for $1.8B to reduce debt and targets higher 2026 profits.

T. Rowe Price's Q4 2025 results show Assets Under Management at $1.62 trillion. Despite net outflows in equities, the firm saw growth in alternatives and strong fixed income performance. Adjusted EPS reached $2.44, supported by a 35.6% operating margin .

Boston Scientific reported strong FY 2025 results , with 15.8% organic revenue growth and adjusted EPS of $3.06. Success was driven by the Watchman and Electrophysiology segments. The company is expanding via acquisitions like Penumbra and new Siemens collaborations .

In 2025, The New York Times achieved record digital revenues exceeding $2 billion, adding 1.4 million subscribers. Leadership plans to scale video journalism and AI-powered products in 2026. Despite rising operating costs , the firm remains focused on margin expansion .

Yum! Brands' Q4 2025 results show strong Taco Bell momentum and record KFC international openings. Despite missing EPS estimates, revenue beat expectations. Growth is driven by the Byte digital platform, while Pizza Hut faces a strategic review and planned U.S. closures.

Clorox reported Q2 2026 results reflecting a digital transformation via a new ERP system . While net sales and gross margins dipped due to high costs and low consumption, the company is acquiring GOJO Industries to expand its health and hygiene portfolio and drive growth.

Supermicro provides modular IT and AI infrastructure through its building-block solutions. The company is scaling rack-scale manufacturing and liquid cooling technologies to support AI training. Financial reports emphasize non-GAAP metrics to track core growth and efficiency.

AMD’s Q4 2025 results surpassed expectations with $10.27 billion in revenue and $1.53 EPS . Driven by Data Center AI growth and strategic acquisitions like ZT Systems , the company expanded its instinct GPU and EPYC portfolios despite ongoing export restrictions .

Chipotle’s 2025 results show revenue growth to $11.9 billion despite a slight dip in comparable sales . The new "Recipe for Growth" strategy targets global expansion and operational efficiency . With a debt-free balance sheet , the firm continues heavy share repurchases .

In 2025, Novo Nordisk achieved 10% sales growth, reaching DKK 309 billion, primarily driven by a 31% surge in obesity care . Key developments include the Wegovy pill launch and pipeline assets like CagriSema . The firm announced a DKK 15 billion share buyback and increased dividends.

Chubb reported record earnings for Q4 2025, with core operating income rising to $2.98 billion. Strong underwriting performance led to a record low combined ratio of 81.2%. Growth was driven by P&C premiums and life insurance , particularly in international consumer markets.

Markets reacted as the U.S. government reopened and the S&P 500 fell 1%. Disney named Josh D’Amaro CEO, while Tulsi Gabbard faces scrutiny over a Georgia election raid. Trump proposed a SALT tax hike and a " Trump Homes " plan to address housing affordability.

Grainger reported 2025 sales of $17.9 billion, navigating inflation and U.K. market exits. While High-Touch Solutions faced margin pressure, Endless Assortment grew. For 2026, the firm expects 6.5%–9.0% organic sales growth and improved operating margins through cost recovery.

Marathon Petroleum reported a strong Q4 2025 , with an adjusted EPS of $4.07 , beating estimates. High refining utilization (95%) and capture rates drove performance. MPC plans a disciplined 2026 capital strategy , reducing refining spend by 20% while leveraging MPLX distributions .

Pfizer’s 2026 strategy focuses on Oncology , Obesity , and R&D milestones . Key priorities include advancing ADCs , monthly GLP-1 candidates, and achieving $7.2B in net cost savings . The firm aims for long-term growth through AI integration and strategic acquisitions .

Merck’s Q4 2025 results highlight the strategic acquisition of Cidara Therapeutics and the clinical success of Winrevair in PAH. Despite a Gardasil sales decline in Asia and generic headwinds, the firm projects a $70 billion pipeline opportunity driven by oncology and HIV gains.

Pentair’s FY2025 results show record performance, with sales up 2% and adjusted operating income rising 10%. Growth was driven by transformation initiatives and pricing. In 2026, the company will realign its Flow and Water Solutions segments to improve efficiency.